Summary
Increased sympathetic activity occurs in congestive heart failure and may have deleterious effects. To examine the effects of angiotensin converting enzyme (ACE) inhibition on sympathetic activity in heart failure, the noradrenaline response to exercise was measured in 18 patients given enalapril or placebo in double-blind trial. The plasma noradrenaline response to graded exercise was significantly reduced after 4 weeks on active treatment but was unchanged by placebo treatment. The rate-pressure product at maximal exercise was significantly reduced after 4 weeks in the enalapril group but unchanged in the placebo group. These results suggest that ACE inhibition reduces sympathetic activity in patients with heart failure.
This is a preview of subscription content, log in via an institution to check access.
References
Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, Hollenberg NK (1980) Sustained effectiveness of convertingenzyme inhibition in patients with severe congestive heart failure. N Engl J Med 302: 1373–1379
McGrath BP, Arnolda L, Matthews PG, Jackson B, Jennings G, Kiat H, Johnston CI (1985) Controlled trials of enalapril in congestive cardiac failure. Br Heart J 54: 405–414
Antonaccio MJ, Kerwin L (1980) Evidence for prejunctional inhibition of noradrenaline release by captopril in spontaneously hypertensive rats. Eur J Pharmacol 68: 209–212
Hatton R, Clough DP (1982) Captopril interferes with neurogenic vasoconstriction by angiotensin — dependant mechanisms. J Cardiovasc Pharmacol 4: 116–123
Hörtnagel H, Benedict CR, Grahame-Smith DG, McGrath B (1977) A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma. Br J Clin Pharmacol 4: 553–558
Boyd GW, Land J, Peart WS (1969) Radioimmunoassay of angiotensin II. Proc R Soc London (Biol) 173: 277
Wood RL, Johnston CI (1982) Role of vasopressin in hypertension: Studies using the Brattleboro rat. Am J Physiol 242: F727-F732
Creager MA, Faxon DP, Weiner DA, Ryan TJ (1985) Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril. Br Heart J 53: 431–5
Francis GS, Goldsmith SR, Ziesche SM, Cohn JN (1982) Response of plasma noradrenaline and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 49: 1152–1156
Sharpe DN, Murphy J, Coxon R, Hannan SF (1984) Enalapril in patients with chronic heart failure: A placebo-controlled, randomized double-blind study. Circulation 70: 271–278
Zimmerman BG, Sybertz EJ, Wong PC (1984) Interaction between sympathetic and renin-angiotensin systems. J Hypertens 2: 581–587
Kohlmann O, Bresnahan M, Gavras H (1984) Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydrallazine in normotensive rats. Hypertension 6 [Suppl I): 1–16
Giudicelli JF, Berdeaux A, Edouard A, Richer C, Jacolot D (1985) The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol 20: 211–218
Cohn JN, Levine BT, Garberg V, Lura D, Francis GS, Simon A, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819–823
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGrath, B.P., Arnolda, L.F. Enalapril reduces the catecholamine response to exercise in patients with heart failure. Eur J Clin Pharmacol 30, 485–487 (1986). https://doi.org/10.1007/BF00607965
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607965